Dec. 18, 2024 — Until now, scientists have been unable to determine how metformin, a Type 2 diabetes medication that lowers blood sugar, works. A study provided direct evidence in mice that it ...

Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...

The status of diabetes mellitus was defined as (1) a fasting glucose level of 7.8 mmol/L or greater and/or a 2-hour glucose level of 11.1 mmol/L or greater, or (2) a history of diabetes mellitus, for ...